Estimation of Residual Tissue with Thyroid Scintigraphy and Thyroglobulin Level in the Pre-ablative Period of Differentiated Thyroid Carcinoma

Yıl 2020, , 169 - 175, 19.09.2020

Hasan Ikbal Atılgan Hulya Yalçın

https://doi.org/10.5455/umj.20200805104357

Öz

Introduction: The aim of the study was to compare the pre-ablative thyroid scintigraphy and serum thyroglobulin (TG) positivity with a therapeutic I-131 scan for the detection of residual tissue.
Materials and Methods: Patients included in the study were those with neck residual tissue only and no residual or metastatic tissue in the ablative radioactive iodine (RAI) scan anywhere in the body. Pre-ablative thyroid scintigraphy for the residual tissue in the neck was obtained from all patients. Ablative TSH, TG and anti-TG levels were measured on the same day or one day before the RAI therapy. The evaluation of neck residual tissue detected with thyroid scintigraphy and TG measurement were made in this study accepting I-131 scan as the gold standard.
Results: The I-131 scan was positive for residual neck tissue in 67 (93.1%) patients and negative in 5 (6.9%) patients. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive values of thyroid scintigraphy were 70.1%, 80%, 70.8%, 97.9%, and 16.7%, respectively. For the high positive predictive value, the kappa value was 0.182, which showed a slight agreement between Tc-99m thyroid scintigraphy and I-131 scan. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive values of TG measurement were 92.5%, 60%, 90.3%, 96.9%, and 37.5%. There was moderate agreement between the TG measurement and I-131 scan.
Conclusion: Negative thyroid scintigraphy should not be noteworthy because of the very low negative predictive value and kappa value. A measurable TG level seems to be more accurate and useful for the detection of residual tissue.

Anahtar Kelimeler

Thyroid cancer, scintigraphy, thyroglobulin

Kaynakça

• Mazzaferri EL, Kloos RT. Clinical review: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–63
• Teoh CM, Rohaizak M, Chan KY, Jasmi AY, Fuad I. Preablative diagnostic whole-body scan following total thyroidectomy for well-differentiated thyroid cancer: is it necessary? Asian J Surg. 2005;28:90–6
• Janovsky CC, Maciel RM, Camacho CP, Padovani RP, Nakabashi CC, Yang JH, et al. A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy. Eur Thyroid J. 2016;5:44-9
• Triggiani V, Giagulli VA, Iovino M, De Pergola G, Licchelli B, Varraso A, et al. False positive diagnosis on (131)iodine whole- body scintigraphy of differentiated thyroid cancers. Endocrine. 2016;53:626-35
• Chantadisai M, Kingpetch K. Usefulness of (99m)Tc- pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients. Ann Nucl Med. 2014;28:674–82
• Holsinger FC, Ramaswamy U, Cabanillas ME, Lang J, Lin HY, Busaidy NL, et al. Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes. JAMA Otolaryngol Head Neck Surg. 2014;140:410-5
• Alzahrani AS, Al Mandil M, Chaudhary MA, Ahmed M, Mohammed GE. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for different thyroid cancer. Surgery. 2002;131:443–9
• Song JSA, Moolman N, Burrell S, Rajaraman M, Bullock MJ, Trites J, et al. Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma. Head Neck. 2018;40(:2129-2136
• Salvatori M, Raffaelli M, Castaldi P, Treglia G, Rufini V, Perotti G, et al. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. Eur J Surg Oncol. 2007;33:648-54
• Ozdemir D, Cuhaci FN, Ozdemir E, Aydin C, Ersoy R, Turkolmez S, Cakir B. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer. Nucl Med Commun. 2016;37:640-5
• Wilson LM, Barrington SF, Morrison ID, Kettle AG, O’Doherty MJ, Coakley AJ. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma.Eur J Nucl Med.1998;25:622-8.
• Ahmed N, Niyaz K, Borakati A, Marafi F, Birk R, Usmani S. Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma. Asian Pac J Cancer Prev. 2018;19:303–8
• Kim S, Park CH, Yoon KN, Hwang K. A false positive I-131 whole body scan in chronic parotitis: a case report. Clin Nucl Med 2001;26:536–7
• Coover LR. False positive result of a total body scan caused by benign thyroidal tissue after I-131 ablation. Clin Nucl Med 1999;24:182–3
• Iwano S, Kato K, Nihashi T, Ito S, Tachi Y, Naganawa S. Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer. Ann Nucl Med. 2009;23:777–82
• Utiger RD. Follow-up of patients with thyroid carcinoma. N Engl J Med 1997;337:928–30
• Kueh SS, Roach PJ, Schembri GP. Role of Tc-99m for remnant scintigraphy post-thyroidectomy. Clin Nucl Med. 2010;35:671–74
• Nadig MR, Pant GS, Bal C. Usefulness of 99mTc- pertechnetate single-photon emission computed tomography in remnant mass estimation of postsurgical patients of differentiated thyroid cancer during internal dosimetry. Nucl Med Commun. 2008;29:809–14
• Giovanella L, Suriano S, Ricci R, Ceriani L, Anton Verburg F. Postsurgical thyroid remnant estimation by Tc99-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma. Head Neck. 2011;33:552–6
• Thientunyakit T, Pusuwan P, Tuchinda P, Khiewvan B. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation [published correction appears in J Med Assoc Thai. 2014 Jan;97(1):138. Kiewvan, Benjapa [corrected to Khiewvan, Benjapa]]. J Med Assoc Thai. 2013;96:1199–207
• Girelli ME, De Vido D. Serum thyroglobulin measurements in differentiated thyroid cancer. Biomed Pharmacother. 2000;54:330–3
• Charles MA, Dodson LE Jr, Waldeck N, Hofeldt F, Ghaed N, Telepak R, et al. Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma. Am J Med. 1980;69:401-7
• Erbil Y, Barbaros U, Salmaslioglu A, Issever H, Tukenmez M, Adalet I, et al. Determination of remnant thyroid volume: comparison of ultrasonography, radioactive iodine uptake and serum thyroid-stimulating hormone level. J Laryngol Otol. 2008;122:615-22
• Zhao T, Liang J, Li T, Guo Z, Vinjamuri S, Lin Y. Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants? Nucl Med Commun 2016;37:632-9
• Cherk MH, Francis P, Topliss DJ, Bailey M, Kalff V. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal. Clin Endocrinol (Oxf). 2012;76:734–40
• Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med. 1998;39:1542–6
• Khammash NF, Halkar RK, Abdel-Dayem HM. The use of technetium-99m pertechnetate in postoperative thyroid a. A comparative study with iodine-131. Clin Nucl Med. 88;13:17–22